1. Home
  2. VERA vs FA Comparison

VERA vs FA Comparison

Compare VERA & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • FA
  • Stock Information
  • Founded
  • VERA 2016
  • FA 2003
  • Country
  • VERA United States
  • FA United States
  • Employees
  • VERA N/A
  • FA N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • FA Business Services
  • Sector
  • VERA Health Care
  • FA Consumer Discretionary
  • Exchange
  • VERA Nasdaq
  • FA Nasdaq
  • Market Cap
  • VERA 2.5B
  • FA 2.9B
  • IPO Year
  • VERA 2021
  • FA 2021
  • Fundamental
  • Price
  • VERA $46.26
  • FA $17.50
  • Analyst Decision
  • VERA Strong Buy
  • FA Buy
  • Analyst Count
  • VERA 9
  • FA 8
  • Target Price
  • VERA $54.33
  • FA $66.20
  • AVG Volume (30 Days)
  • VERA 1.1M
  • FA 1.5M
  • Earning Date
  • VERA 11-07-2024
  • FA 11-12-2024
  • Dividend Yield
  • VERA N/A
  • FA N/A
  • EPS Growth
  • VERA N/A
  • FA N/A
  • EPS
  • VERA N/A
  • FA 0.03
  • Revenue
  • VERA N/A
  • FA $755,643,000.00
  • Revenue This Year
  • VERA N/A
  • FA $4.07
  • Revenue Next Year
  • VERA N/A
  • FA $7.48
  • P/E Ratio
  • VERA N/A
  • FA $615.86
  • Revenue Growth
  • VERA N/A
  • FA N/A
  • 52 Week Low
  • VERA $12.28
  • FA $13.88
  • 52 Week High
  • VERA $51.61
  • FA $20.79
  • Technical
  • Relative Strength Index (RSI)
  • VERA 54.02
  • FA 38.38
  • Support Level
  • VERA $47.16
  • FA $18.35
  • Resistance Level
  • VERA $51.61
  • FA $20.79
  • Average True Range (ATR)
  • VERA 2.99
  • FA 0.80
  • MACD
  • VERA 0.21
  • FA -0.01
  • Stochastic Oscillator
  • VERA 52.82
  • FA 7.58

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About FA First Advantage Corporation

First Advantage Corp is a provider of employment background screening and verification solutions. The company delivers services and insights that help its customers manage risk and hire talent. The Company has two reportable segments, Americas and International. The Americas segment provides technology solutions for screening, verifications, safety, and compliance in the United States, Canada, and Latin America markets. and the International segment provides technology solutions for screening, verifications, safety, and compliance outside of the Americas. The company derives its maximum revenue from America.

Share on Social Networks: